• 1
    Hanno PM. Interstitial cystitis – epidemiology, diagnostic criteria, clinical markers. Rev. Urol. 2002; 4 (Suppl. 1): S38.
  • 2
    Hanno PM, Landis JR, Matthews-Cook Y, Kusek J, Nyberg L Jr. The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study. J. Urol. 1999; 161: 5537.
  • 3
    Kuehr J, Brauburger J, Zielen S et al. Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis. J. Allergy Clin. Immunol. 2002; 109: 27480.
  • 4
    Norman PS. Immunotherapy: 1999–2004. J. Allergy Clin. Immunol. 2004; 113: 101323.
  • 5
    MacGlashan DW, Bochner BS, Adelman DC et al. Down-regulation of Fc∈RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J. Immunol. 1997; 158: 143845.
  • 6
    Beck LA, Marcotte GV, MacGlashan D, Togias A, Saini S. Omalizumab-induced reductions in mast cell FcɛRI expression and function. J. Allergy Clin. Immunol. 2004; 114: 52730.
  • 7
    Gillenwater JY, Wein AJ. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, NIH, Bethesda, MD, August 28–29, 1987. J. Urol. 1988; 140: 2036.
  • 8
    Parsons CL, Benson G, Childs SJ, Hanno P, Sant GR, Webster G. A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate. J. Urol. 1993; 150: 8458.
  • 9
    Bade JJ, Laseur M, Nieuwenburg A, Van Der Weele LT, Mensink HJ. A placebo-controlled study of intravesical pentosanpolysulphate for the treatment of interstitial cystitis. Br. J. Urol. 1997; 79: 16871.
  • 10
    Peters KM, Diokno AC, Steinert BW, Gonzalez JA. The efficacy of intravesical Tice strain bacillus Calmette-Guerin in the treatment of interstitial cystitis: a double-blind, prospective, placebo controlled trial. J. Urol. 1997; 157: 20904.
  • 11
    Holm-Bentzen M, Jacobsen F, Nerstrom B et al. A prospective double-blind clinically controlled multicenter trial of sodium pentosanpolysulfate in the treatment of interstitial cystitis and related painful bladder disease. J. Urol. 1987; 138: 5037.
  • 12
    Peeker R, Haghsheno MA, Holmäng S, Fall M. Intravesical bacillus Calmette-Guerin and dimethyl sulfoxide for treatment of classic and nonulcer interstitial cystitis: a prospective, randomized double-blind study. J. Urol. 2000; 164: 191216.
  • 13
    Yamada T. Significance of complications of allergic diseases in young patients with interstitial cystitis. Int. J. Urol. 2003; 10 (Suppl.): S568.
  • 14
    Yamada T, Murayama T, Mita H, Akiyama K, Taguchi H. Alternate occurrence of allergic disease and an unusual form of interstitial cystitis. Int. J. Urol. 1998; 5: 32936.
  • 15
    Sant GR, Theoharides TC, Letourneau R, Gelfand J. Interstitial cystitis and bladder mastocytosis in a woman with chronic urticaria. Scand. J. Urol. Nephrol. 1997; 31: 497500.
  • 16
    Hanno P. Painful bladder syndromes. In: Hanno PM, Malkowicz SB, Wein AJ (eds). Clinical Manual of Urology. McGraw–Hill, New York, 2001; 199212.
  • 17
    Wein AJ, Hanno PM. Targets for therapy of the painful bladder. Urology 2002; 59 (Suppl. 5A): 6873.